The 2025 MSTS Specialty Day was held on Friday, March 14, 2025.

Under the leadership of Chair Dr. Panos Papagelopoulos, Planning Committee members Drs. Alan Blank and Alexander Lazarides developed an excellent full-
day program with a focus on metastatic bone disease, the utilization of machine learning and artificial intelligence in the development of novel technologies and treatment and expanding partnerships with sarcoma patient advocacy groups and non-profit organizations with a specific highlight on patient experience and the future education and research.  

Click here to view the MSTS 2025 Specialty Day Program Agenda.